Cargando…

Lipid Droplet-Associated Factors, PNPLA3, TM6SF2, and HSD17B Proteins in Hepatopancreatobiliary Cancer

SIMPLE SUMMARY: Aberrant lipid synthesis and reprogrammed lipid metabolism are both associated with the development and progression of pancreatic and liver cancer. Most cells store fatty acids in the form of triacylglycerols in lipid droplets. Lipid droplets are intracellular organelles that not onl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sunami, Yoshiaki, Rebelo, Artur, Kleeff, Jörg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431307/ https://www.ncbi.nlm.nih.gov/pubmed/34503201 http://dx.doi.org/10.3390/cancers13174391

Ejemplares similares

Lipid Metabolism and Lipid Droplets in Pancreatic Cancer and Stellate Cells
por: Sunami, Yoshiaki, et al.
Publicado: (2017)

Identification of prognostic lipid droplet-associated genes in pancreatic cancer patients via bioinformatics analysis
por: Bai, Rubing, et al.
Publicado: (2021)

Combined effects of PNPLA3, TM6SF2 and HSD17B13 variants on severity of biopsy-proven non-alcoholic fatty liver disease
por: Paternostro, Rafael, et al.
Publicado: (2021)

Cholesterol Metabolism in Pancreatic Cancer
por: Rebelo, Artur, et al.
Publicado: (2023)

PNPLA3 and TM6SF2 polymorphisms in Brazilian patients with nonalcoholic fatty liver disease
por: Lisboa, Quelson Coelho, et al.
Publicado: (2020)

The additive effects of the TM6SF2 E167K and PNPLA3 I148M polymorphisms on lipid metabolism
por: Chen, Lizhen, et al.
Publicado: (2017)

Fibroblast Activation Protein Overexpression in Gastrointestinal Tumors: Protocol for a Systematic Review and Meta-analysis
por: Sunami, Yoshiaki, et al.
Publicado: (2023)

NAFLD risk alleles in PNPLA3, TM6SF2, GCKR and LYPLAL1 show divergent metabolic effects
por: Sliz, Eeva, et al.
Publicado: (2018)

Identification of deleterious rare variants in MTTP, PNPLA3, and TM6SF2 in Japanese males and association studies with NAFLD
por: Boonvisut, Supichaya, et al.
Publicado: (2017)

Relationships between Genetic Variations of PNPLA3, TM6SF2 and Histological Features of Nonalcoholic Fatty Liver Disease in Japan
por: Akuta, Norio, et al.
Publicado: (2016)

The role of PNPLA3 and TM6SF2 polymorphisms on liver fibrosis and metabolic abnormalities in Brazilian patients with chronic hepatitis C
por: Oliveira, Arthur Ivan N., et al.
Publicado: (2021)

Association of PNPLA3 rs738409 and TM6SF2 rs58542926 with health services utilization in a population-based study
por: Köpp, Julia, et al.
Publicado: (2016)

NOTCH3 rs1043996 Polymorphism Is Associated with the Occurrence of Alcoholic Liver Cirrhosis Independently of PNPLA3 and TM6SF2 Polymorphisms
por: Bainrauch, Ana, et al.
Publicado: (2021)

Interplay of PNPLA3 and HSD17B13 Variants in Modulating the Risk of Hepatocellular Carcinoma among Hepatitis C Patients
por: De Benedittis, Carla, et al.
Publicado: (2020)

Additive Effects of the Risk Alleles of PNPLA3 and TM6SF2 on Non-alcoholic Fatty Liver Disease (NAFLD) in a Chinese Population
por: Wang, Xiaoliang, et al.
Publicado: (2016)

Accumulation of PNPLA3 on lipid droplets is the basis of associated hepatic steatosis
por: BasuRay, Soumik, et al.
Publicado: (2019)

Interaction of the Lysophospholipase PNPLA7 with Lipid Droplets through the Catalytic Region
por: Chang, Pingan, et al.
Publicado: (2020)

Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis
por: Smagris, Eriks, et al.
Publicado: (2015)

TM6SF2/PNPLA3/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In Vitro Models
por: Longo, Miriam, et al.
Publicado: (2021)

Influence of Type 2 Diabetes in the Association of PNPLA3 rs738409 and TM6SF2 rs58542926 Polymorphisms in NASH Advanced Liver Fibrosis
por: Gabriel-Medina, Pablo, et al.
Publicado: (2022)

PNPLA3 and TM6SF2 genetic variants and hepatic fibrosis and cirrhosis in Pakistani chronic hepatitis C patients: a genetic association study
por: Rauff, Bisma, et al.
Publicado: (2022)

Identification of Diverse Lipid Droplet Targeting Motifs in the PNPLA Family of Triglyceride Lipases
por: Murugesan, Sricharan, et al.
Publicado: (2013)

Coding variants in PNPLA3 and TM6SF2 are risk factors for hepatic steatosis and elevated serum alanine aminotransferases caused by a glucagon receptor antagonist
por: Guzman, Cristina B., et al.
Publicado: (2018)

PNPLA3, TM6SF2, and MBOAT7 Influence on Nutraceutical Therapy Response for Non-alcoholic Fatty Liver Disease: A Randomized Controlled Trial
por: Dallio, Marcello, et al.
Publicado: (2021)

Severity of Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Mellitus: Relationship between Nongenetic Factors and PNPLA3/HSD17B13 Polymorphisms
por: Bellan, Mattia, et al.
Publicado: (2019)

Metabolic disorders induced by PNPLA3 and TM6SF2 gene variants affect chronic kidney disease in patients infected with non-genotype 3 hepatitis C virus
por: Liu, Jia, et al.
Publicado: (2023)

Myeloid TM6SF2 Deficiency Inhibits Atherosclerosis
por: Zhu, Wenzhen, et al.
Publicado: (2022)

Cellular Heterogeneity of Pancreatic Stellate Cells, Mesenchymal Stem Cells, and Cancer-Associated Fibroblasts in Pancreatic Cancer
por: Sunami, Yoshiaki, et al.
Publicado: (2020)

Targeting and Reprograming Cancer-Associated Fibroblasts and the Tumor Microenvironment in Pancreatic Cancer
por: Sunami, Yoshiaki, et al.
Publicado: (2021)

Recent developments in hepatopancreatobiliary EUS
por: Cazacu, Irina M., et al.
Publicado: (2019)

Intraoperative Imaging in Hepatopancreatobiliary Surgery
por: Husarova, Tereza, et al.
Publicado: (2023)

Intestinal autotransplantation: the next level of complexity in locally advanced pancreatic cancer
por: Rebelo, Artur, et al.
Publicado: (2023)

Perturbation of TM6SF2 Expression Alters Lipid Metabolism in a Human Liver Cell Line
por: Pant, Asmita, et al.
Publicado: (2021)

Hepatic TM6SF2 Is Required for Lipidation of VLDL in a Pre-Golgi Compartment in Mice and Rats
por: Luo, Fei, et al.
Publicado: (2021)

Current role of trisectionectomy for hepatopancreatobiliary malignancies
por: Kron, Philipp, et al.
Publicado: (2019)

Brain metastases from hepatopancreatobiliary malignancies
por: Bergen, Elisabeth S., et al.
Publicado: (2023)

Hepatopancreatobiliary malignancies: time to treatment matters
por: Kerekes, Daniel M., et al.
Publicado: (2023)

Three Members of Transmembrane-4-Superfamily, TM4SF1, TM4SF4, and TM4SF5, as Emerging Anticancer Molecular Targets against Cancer Phenotypes and Chemoresistance
por: Rahim, Nur Syafiqah, et al.
Publicado: (2023)

The phospholipase PNPLA7 functions as a lysophosphatidylcholine hydrolase and interacts with lipid droplets through its catalytic domain
por: Heier, Christoph, et al.
Publicado: (2017)

Independent and joint correlation of PNPLA3 I148M and TM6SF2 E167K variants with the risk of coronary heart disease in patients with non-alcoholic fatty liver disease
por: Wu, Jian-Ting, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sh46coc8eu0j14kouvo79j6ffg